6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR)

•First study to evaluate the validity of 6MWT in hATTR patients.•6MWT correlated with FAP stage, PND score and scales capturing neuropathic dysfunction.•6MWT correlated neither with cardiomyopathy nor with autonomic dysfunction.•6MWT is a sensitive tool to detect worsening or stabilization of periph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuromuscular disorders : NMD 2019-03, Vol.29 (3), p.213-220
Hauptverfasser: Vita, Gian Luca, Stancanelli, Claudia, Gentile, Luca, Barcellona, Costanza, Russo, Massimo, Di Bella, Gianluca, Vita, Giuseppe, Mazzeo, Anna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!